SYN - Synthetic Biologics Inc. (SYN) CEO Steven Shallcross on Q4 2019 Results - Earnings Call Transcript
Synthetic Biologics, Inc. (SYN)
Q4 2019 Earnings Conference Call
February 20, 2020 4:30 PM ET
Company Participants
Vincent Perrone - Director, Corporate Communications
Steven Shallcross - Chief Executive Officer and Chief Financial Officer
Vince Wacher - Head of Product and Corporate Development
Conference Call Participants
Michael Okunewitch - Maxim Group
Presentation
Operator
Good afternoon and welcome to Synthetic Biologics' 2019 Year End Investor Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being recorded.
At this time, I would like to turn the call over to Vincent Perrone,